Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone

Pediatrics

Volumn 125, Issue 5, 2010, Pages

  Ularntinon, Sirirat ^a   Tzuang, Dan ^a   Dahl, Gary ^a   Shaw, Richard J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosteroid; Pediatrics; Psychosis; Risperidone

Indexed keywords

DEXAMETHASONE; PREDNISONE; RISPERIDONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGITATION; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CHILD; CORTICOSTEROID THERAPY; DELUSION; DRUG DOSE INCREASE; DRUG EFFICACY; EVENING DOSAGE; HUMAN; IRRITABILITY; MALE; MOOD CHANGE; MOOD DISORDER; MORNING DOSAGE; MULTIPLE CYCLE TREATMENT; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; SIDE EFFECT; SYMPTOM; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADOLESCENT; ANTINEOPLASTIC AGENTS, HORMONAL; ANTIPSYCHOTIC AGENTS; CHILD; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MOOD DISORDERS; PITUITARY-ADRENAL SYSTEM; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; PSYCHOSES, SUBSTANCE-INDUCED; RECURRENCE; RISPERIDONE;

EID: 77951791668     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-1815     Document Type: Article

References (37)

1. Drigan R, Spirito A, Gelber RD. Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia. Med Pediatr Oncol. 1992;20(1):13-21
2. Harris JC, Carel CA, Rosenberg LA, Joshi P, Leventhal BG. Intermittent high dose corticosteroid treatment in childhood cancer: behavioral and emotional consequences. J Am Acad Child Psychiatry. 1986;25(1):120-124
3. Hall AS, Thorley G, Houtman PN. The effects of corticosteroids on behavior in children with nephrotic syndrome. Pediatr Nephrol. 2003;18(12):1220-1223 (Pubitemid 37527094)
4. Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol. 1998;25(10):1995-2002
5. Kayani S, Shannon DC. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest. 2002;122(2):624-628 (Pubitemid 35002146)
6. Bender BG, Lerner JA, Kollasch E. Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry. 1988;27(6):720-772 (Pubitemid 19003711)
7. Felder-Puig R, Scherzer C, Baumgartner M, et al. Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and Hodgkin's disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers. Clin Cancer Res. 2007;13(23):7093-7100
8. Stuart FA, Segal TY, Keady S. Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child. 2005;90(5):500-506
9. French J, Khan A, White H. Steroid induced psychosis in an asthmatic child: case report & 10 year literature review. Can Child Adolesc Psychiatr Rev. 2003;12(4):117-118
10. Hochhauser CJ, Lewis M, Kamen BA, Cole PD. Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia. Support Care Cancer. 2005;13(12):967-974
11. Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361-1367
12. Sirois F. Steroid psychosis: a review. Gen Hosp Psychiatry. 2003;25(1):27-33
13. Wada K, Yamada N, Sato T, et al. Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics. 2001;42(6):461-466
14. Stiefel FC, Breitbart WS, Holland JC. Corticosteroids in cancer: neuropsychiatric complications. Cancer Invest. 1989;7(5):479-491
15. Brown ES, Chandler PA. Mood and cognitive changes during systemic corticosteroid therapy. Prim Care Companion J Clin Psychiatry. 2001;3(1):17-21
16. Brown ES, Chamberlain W, Dhanani N, Paranjpe P, Carmody TJ, Sargeant M. An open-label trial of olanzapine for corticosteroid-induced mood symptoms. J Affect Disord. 2004;83(2-3):277-281
17. Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotropin-induced psychosis. JAMA. 1979;241(10):1011-1012
18. Kramer TM, Cottingham EM. Risperidone in the treatment of steroid-induced psychosis. J Child Adolesc Psychopharmacol. 1999;9(4):315-316
19. Ingram DG, Hagemann TM. Promethazine treatment of steroid-induced psychosis in a child. Ann Pharmacother. 2003;37(7-8):1036-1039
20. McGrath P, Pitcher L. "Enough is enough": qualitative findings on the impact of dexamethasone during reinduction/consolidation for pediatric acute lymphoblastic leukemia. Supportive Care Cancer. 2002;10(2):146-155
21. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res. 1985;19(1):57-64
22. Brown ES, Woolston DJ, Frol A, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry. 2004;55(5):538-545
23. Brown ES, Vera E, Frol AB, Woolston DJ, Johnson B. Effects of chronic prednisone therapy on mood and memory. J Affect Disord. 2007;99(1-3):279-283
24. Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S. Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann N Y Acad Sci. 1997;823:81-96
25. Nishimura K, Harigai M, Omori M, Sato E, Hara M. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erye1244 thematosus. Psychoneuroendocrinology. 2008;33(3):395-403
26. Balis FM, Poplack DG. Central nervous system pharmacology of antileukemic drugs. Am J Pediatr Hematol Oncol. 1989;11(1):74-86
27. Riccardi R, Riccardi A, Lasorella A, Servidei T, Mastrangelo S. Cranial irradiation and permeability of blood-brain barrier to cytosine arabinoside in children with acute leukemia. Clin Cancer Res. 1998;4(1):69-73
28. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008;13(12):1285-1295
29. Oyesanmi O, Kunkel EJ, Monti DA, Field HL. Hematologic side effects of psychotropics. Psychosomatics. 1999;40(5):414-421
30. Walker E, Mittal V, Tessner K. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol. 2008;4:189-216
31. Goff DC. Risperidone. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. Arlington, VA: American Psychiatric Publishing, Inc; 2004:495-1450
32. Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. CMAJ. 2005;172(13):1703-1711
33. Kapur S, Seeman P. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry. 2001;158(3):360-369
34. Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem. 2001;76(5):1521-1531
35. Casey DE. Side effect profiles of new antipsychotic agents. J Clin Psychiatry. 1996; 57(suppl 11):40-45
36. Collaborative Working Group on Clinical Trial Evaluations. Adverse effects of the atypical antipsychotics. J Clin Psychiatry. 1998;59(suppl 12):17-22
37. Dasilva CC, Murse MC, Vokey K. Steroid induced psychosis treated with risperidone. Can J Psychiatry. 2002;47(4):388-389